Navigation Links
Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign
Date:11/3/2008

BEDFORD, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the global leader in patch pump technology, and the International Diabetes Federation (IDF) today announced that Insulet is an official partner of IDF's World Diabetes Day (WDD) campaign. World Diabetes Day, celebrated on November 14, will raise awareness of children and adolescents with diabetes, spotlighting both the impact of the disease and access to care.

"Insulet's mission is to improve the lives of people with diabetes, so we felt it was imperative to join IDF to increase global awareness of this devastating disease, which affects millions of people worldwide," said Duane DeSisto, Insulet's president & chief executive officer. "Our easy-to-use OmniPod(R) Insulin Management System helps people with diabetes stay healthy while living life fully. OmniPod's innovative, tubing-free design provides all the benefits of pump therapy, which supplies the best control over diabetes, while eliminating the hassles of a traditional pump. Its virtually pain-free automated insertion has no needles in sight, which appeals to both children and adults. But primarily, OmniPod enables people with diabetes to simply live their lives normally."

The campaign also emphasizes that, with the right treatment, children and adolescents can live full, healthy and productive lives. To ensure this, it's vital that parents know the early warning signs of diabetes and if their child shows these signs, to seek immediate medical attention. These signs include:

-- Frequent urination

-- Excessive thirst

-- Increased hunger

-- Rapid weight loss

-- Tiredness

-- Lack of interest and concentration

-- Blurred vision

-- Vomiting and stomach pain (often mistaken as the flu)

"We are extremely pleased that Insulet is an official partner in World Diabetes Day and very much welcome their support and expertise in diabetes to bring attention to the disease," said World Diabetes Day Campaign Director Phil Riley.

Introduced by IDF and the World Health Organization in 1991, World Diabetes Day is celebrated every year on November 14 because it marks the birthday of Frederick Banting, who, along with Charles Best, is credited with the discovery of insulin. All WDD partners share the goal of increasing diabetes awareness, care and priority in the world health arena.

In addition to partnering in the WDD campaign, Insulet is focused on raising awareness of diabetes during November, National Diabetes Awareness Month, through a series of local market efforts in cities throughout the United States.

About Type 1 Diabetes

Type 1 diabetes is an autoimmune disease characterized by the destruction of more than 90% of the body's insulin-producing cells. It can neither be prevented nor cured. Globally, it is the most common form of diabetes in children, affecting around 500,000 children under 15, with 70,000 new cases diagnosed each year. Prevalence is increasing most quickly among pre-school children, at a rate of 5% per year.

About the International Diabetes Federation

The International Diabetes Federation (IDF) is an umbrella organization of over 200 member associations in more than 160 countries, advocating for the more than 250 million people with diabetes, their families, and their healthcare providers. Its mission is to promote diabetes care, prevention and a cure worldwide. The International Diabetes Federation is an NGO in official relations with the World Health Organization and an associated NGO with the United Nations Department of Public Information. The International Diabetes Federation leads the World Diabetes Day and Unite for Diabetes campaigns. Additional information is available at http://www.idf.org

About the OmniPod Insulin Management System

Cleared by the Food & Drug Administration (FDA) in January 2005, the OmniPod Insulin Management System offers people living with insulin-requiring diabetes unprecedented freedom, comfort and ease in managing their diabetes. The System currently consists of two devices, the compact, lightweight OmniPod, which is worn discreetly beneath clothing and delivers precise, personalized doses of insulin based on instructions programmed wirelessly using its companion, the handheld, wireless Personal Diabetes Manager (PDM). The OmniPod features no tubing and virtually pain-free automated insertion. The PDM, which is very similar in look and feel to a personal digital assistant, features an integrated blood glucose meter, disease management software and integrated storage and display of all insulin delivery, blood glucose and carbohydrate records.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.

Contact:

Rachel Kessler, Lazar Partners

(917) 660-0608

Mark Sahl, Lazar Partners

(646) 871-8485


'/>"/>
SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: